#USA #Teaneck #Cognizant #AI Lab #RHEA

Cognizant’s AI Lab Achieves Milestone with New Patents

In an exciting development for artificial intelligence, Cognizant's AI Lab has recently secured two new U.S. patents, bringing its total count to an impressive 59. Alongside this achievement, the lab has also received a prestigious Gold Award for a research paper presented at the GECCO (Genetic and Evolutionary Computation Conference) in Malaga, Spain. This recognition emphasizes the lab's ongoing commitment to innovation and excellence in AI technology.

New Innovations on Display

The newly awarded U.S. Patent No. 12,282,845, granted on April 22, 2025, introduces a method for the multi-objective co-evolution of deep neural network architectures. This innovative approach aims to enhance both model performance and resource efficiency, with applications ranging from medical image classification to natural language processing.

Another noteworthy patent, U.S. Patent No. 12,292,944, granted on May 6, 2025, outlines a method for optimizing loss functions through Taylor Series Expansion. This method is designed to improve training efficiency and bolster model robustness, particularly in scenarios with limited data.

These remarkable inventions, crafted by Cognizant researchers such as Dr. Jason Liang, Dr. Elliot Meyerson, and Professor Risto Miikkulainen, solidify Cognizant's leading role in pushing the boundaries of AI and machine learning.

Transforming Business with Neuro AI

To make AI's promise both practical and widely accessible, Cognizant's AI Lab launched its Neuro AI Multi-Agent Accelerator earlier this year. This platform helps businesses expedite the development and deployment of AI agents, transforming their business processes for adaptive workflows, real-time decisions, and personalized customer experiences based on defined goals.

In March 2024, the AI Lab unveiled its flagship research facility in San Francisco. It was here that the lab received the Gold Award for Human-Competitive Results at GECCO 2025 for its innovative work on RHEA (Realizing Human Expertise through AI). Developed by Dr. Elliot Meyerson and Professor Risto Miikkulainen, RHEA utilizes evolutionary AI to refine and re-combine hundreds of models created by human expert teams, particularly those submitted for the XPRIZE Pandemic Response Challenge. In rigorous evaluations, RHEA surpassed the performance of individual human contributions, tapping into potential within underdeveloped human ideas to generate innovative policy recommendations for pandemic responses.

Leading the Charge in AI Innovation

Risto Miikkulainen, Vice President of Research and Professor of Computer Science at the University of Texas at Austin, remarked, "RHEA serves as a powerful example of how evolutionary AI can augment global human intelligence—by not only matching expert solutions but also surpassing them to discover new, high-impact strategies." This recognition from the Humies Award committee underscores the promise of population-based AI as a foundation for addressing the world's most complex challenges.

Cognizant's Impact on Everyday Life

Cognizant (NASDAQ: CTSH) is on a mission to modernize businesses by helping clients transform technologies, processes, and experiences to improve their leads in today's fast-paced environment. Together, they aim to enhance everyday life.

Cognizant's AI Lab is dedicated to maximizing human potential through Decision AI—a blend of generative AI, multi-agent architecture, deep learning, and evolutionary AI to create advanced decision-making systems. This forms the basis of Cognizant's Neuro® AI platform, adopted by Fortune 500 companies and non-profits alike to surpass their goals. With a growing portfolio of over 120 patents (granted or pending) globally, the lab is distinguished for merging scientific innovations with commercial applications, emphasizing responsible development of groundbreaking AI solutions.

To learn more about Cognizant and its pioneering initiatives, visit www.cognizant.com or follow them on Twitter at @cognizant.